340B Advocacy Alliance Bulletin
The AHA today urged the Health Resources and Services Administration to take immediate action to stop a new Novo Nordisk policy from taking effect by April 1.
The Health Resources and Services Administration today said it will extend the deadline to April 20 to receive comments.
Hospitals should submit letters to HRSA by March 19.
The American Hospital Association 340B Advocacy Alliance Bulletin for February 19, 2026.
The AHA Feb. 19 at 3 p.m. ET will host a call to discuss the Department of Health Human Services’ request for information on a new 340B rebate model program.
The Department of Health and Human Services today issued a request for information on a new 340B rebate model program.
The AHA has submitted a statement for the hearing and issued a Member Advisory containing several resources to assist hospitals and health systems in discussing these issues.
New administrative process begins on 340B rebate models; hospitals should begin working on comment letters now.
Blog: 340B is a Solution, not a Threat to Health Care Affordability
AHA urges HRSA to stop Eli Lilly’s new claims-data submission policy on 340B hospitals from going into effect; hospitals urged to submit their own letters to HRSA and use AHA letter as a guide.